worsening acne in 6% of LNG-IUD users.
Efficacy of NB-UVB, microneedling with triamcinolone acetonide, and a combination of both modalities in the treatment of vitiligo: A comparative study
To the Editor: Vitiligo has a great impact on the physical and mental health of patients, including loss of skin photoprotection, impaired cutaneous immunity, and marked reduction in quality of life. Therapeutic options for stabilizing and repigmenting vitiligo have been modestly expanded in recent years without a completely satisfactory outcome. 1 Narrowband ultraviolet B (NB-UVB) is considered the criterion standard in vitiligo treatment, with a high repigmentation rate that is further J AM ACAD DERMATOL VOLUME 79, NUMBER 2 increased when combined with other therapeutic options. 2 Needling is a new technique that is believed to induce pigmentation in vitiliginous areas by physically moving melanocytes with the needle from the pigmented areas into the depigmented areas so that they can serve as reservoirs for melanogenesis 3 and be used as a transdermal drug delivery modality. 4 This technique has been used in conjunction with NB-UVB and produced favorable results. 3 Our aim was to compare the efficacy of needling with topical steroid alone or in combination with NB-UVB versus NB-UVB as a standard treatment modality.
This was a comparative study (Zagazig University institutional review board approval No.: 3707/24-2-2016) involving 60 patients with acrofacial vitiligo collected from the Dermatology, Venereology and Andrology Department of the Faculty of Medicine of Zagazig University.
Patients were randomly divided into 3 groups: (1) patients treated with NB-UVB therapy applied in a Waldmann cabin UV 1000L 230v (Waldmann GmbH, Vinningen-Schwennigen, Germany); (2) patients treated with needling once weekly for 3 months using Derma stamp electric pen (My-M dermapen, Bomtech Electronics, Seoul, Korea), followed by topical application of triamcinolone acetonide solution (10 mg/mL); and (3) patients treated with a combination of both modalities. The effectiveness of the treatment was evaluated by the percentage of repigmentation in grades as follows: G0, no response; G1, fair (\25%) response; G2, moderate (25%-50%) response; G3, good (51%-75%) response; and G4, excellent ([75%) response.
Analysis of the demographic data showed 27 male (45%) and 33 female (55%) patients ranging in age from 13 to 50 years. Vitiligo duration ranged from 5 to 60 months. With regard to treatment outcome (Table I) , there was no statistically significant difference between the groups, with the best outcome in group 3, in which 40% of patients had a good response and 30% had an excellent response. In group 1, 20% of patients had a good response and none had an excellent response, and in group 2, 30% of patients had a good response and 15% had an excellent response. There was a statistically significant difference between the groups (P ¼ .024) with regard to satisfaction, with 40% of patients in group 3 expressing excellent satisfaction (Table I) . Different treatment options for vitiligo, acting either on proliferation of melanocytes or suppression of immune response, have been used. Recent procedures, including needling, have shown acceptable degrees of repigmentation in limited types of vitiligo.
In a comparison of the results of needling plus a topical steroid with NB-UVB and an examination of the additional value of a using combination of both modalities in acrofacial vitiligo, needling yielded a good-to-excellent response in 45% of cases, whereas combining needling with NB-UVB raised that percentage to 70%. The overall incidence of side effects was minimal, except for pain, which can be minimized by using topical anesthetics before sessions.
In conclusion, the addition of needling to NB-UVB is a reasonable combination therapy for patients with resistant vitiligo and is well tolerated. Biopsy techniques and pathology reporting preferences are in Table I . All respondents indicated they perform diagnostic biopsies intending to remove the entire pigmented lesion, with roughly equal preference for shave/saucerization removal (55%) versus full-thickness ( punch, elliptical) excision (45%). The vast majority (92%) use pathologists who grade nevus atypia and dysplasia on a mild/moderate/severe scale, and most (74%) preferred such grading.
Recommendations after initial biopsy are in Table II . For scenarios in which the diagnostic biopsy removed the clinically visible lesion but there were positive microscopic margins, there was near universal agreement for 3 scenarios: 1) nevi with mild dysplasia do not require re-excision; 2) nevi with severe dysplasia require an additional procedure, although recommendations for clinical margins varied widely; and 3) atypical spitz nevi in an adult also require an additional procedure, but again with varying margin recommendations. Recommendations for nevi with moderate atypia or classic spitz nevi in an adult varied widely, with no consensus. Prior surveys of general dermatologists found even broader ranges of management for dysplastic nevi. 2, 3 For nevi with severe atypia and atypical spitz nevi in adults with negative microscopic margins, there was no management consensus.
Eight (28%) participants recommended a sentinel node biopsy for at least some adults with an atypical spitz nevus with negative histologic
